Med Investors Development, LLC – Trademark Portfolio

Entity Type: 16

Med Investors Development, LLC holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 6 filings in this category. Currently, 4 trademarks are registered. Notable registered marks include TEXTCARE, ONE TO ONE HEALTH, HEALTHCARE THAT CARES, and CONCIERGE MEDICINE, FOR ALL. The owner is based in Chattanooga, TN.

Suite 201

1067 Riverfront Parkway

Chattanooga, TN 374022222

6 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Med Investors Development, LLC's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

44
Medical Services (6 filings)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does Med Investors Development, LLC have?

Med Investors Development, LLC has 6 U.S. trademarks filed with the USPTO. Of these, 4 registered, 2 abandoned.

What trademark classes does Med Investors Development, LLC file in?

Med Investors Development, LLC files trademarks across 1 Nice Classification class. The most active classes are Class 44 (Medical Services). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.

What are Med Investors Development, LLC's most well-known trademarks?

Med Investors Development, LLC's registered trademark portfolio includes well-known marks such as TEXTCARE, ONE TO ONE HEALTH, HEALTHCARE THAT CARES, and CONCIERGE MEDICINE, FOR ALL. These are among 4 currently registered trademarks in the portfolio.

What is Med Investors Development, LLC's trademark registration success rate?

Med Investors Development, LLC has a 67% trademark registration rate, with 4 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.